Difference between revisions of "WSI21-148-Case-1"

From MGH Learn Pathology
(Added status template)
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
−
{{dziCase
+
{{ServiceRequestCase
−
|qc=yes
+
|identifier=WSI21-148-Case-1
−
|qcuser=Aja51
+
|intent=order
−
|qctime=Sep 10, 2021 16:50:23
+
|category=409073007
−
|order_date=September 08, 2021 03:22:10 PM
+
|priority=routine
−
|user=Rmn6
+
|orderDetail=case
−
|dziorder=WSI21-148
+
|locationCode=learn
−
|case_id=1
+
|basedOn=WSI21-148
−
|publish_timestamp=2021/11/04 09:00
+
|code=faculty
−
|clinical_hx=61 yo M, left upper arm skin excision. Rule out pleomorphic dermal sarcoma.
+
|supportingInfo=Spindled cell/desmoplastic melanoma, level IV (at least), 1.2mm thickness (at least), non-ulcerated, non-mitotic, non-brisk tumor infiltrating lymphocytes, no regression, perineural invasion and microsatellites cannot be assessed. The tumor extends to deep and side margins. PRAME and SOX10 IHC stain positive in epidermal and dermal components, FXIII IHC is negative in lesional cells.
−
|case_diagnosis=Spindled cell/desmoplastic melanoma, level IV (at least), 1.2mm thickness (at least), non-ulcerated, non-mitotic, non-brisk tumor infiltrating lymphocytes, no regression, perineural invasion and microsatellites cannot be assessed. The tumor extends to deep and side margins. PRAME and SOX10 IHC stain positive in epidermal and dermal components, FXIII IHC is negative in lesional cells.
+
|reasonCode=61 yo M, left upper arm skin excision. Rule out pleomorphic dermal sarcoma.
−
|case_notes=prame case
+
|subject=MGH
 +
|performer=RMN6
 +
|authoredOn=September 08, 2021 03:22:10 PM
 +
|requester=Rmn6
 +
|sequence=1
 +
|access=public
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=September 08, 2021 03:22:10 PM
+
|basedOn=WSI21-148-Case-1
−
|user=Rmn6
+
|type=image
−
|source_filename=Z0FBQUFBQmhPTlZFdXNVSjlQeUN2TkVldHdFcEdxamV5M0RvNXhHOWFQQ19RaUg3V3NuOVo1aHN3Q0hjaGFvTFROcHVsdkxISUZJdnd3aVUwLUR2N0EteWVRTXhxVklIX0E9PQ
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-148
−
|slide_anatomy=Show
+
|frames=1
 +
|reasonCode=H&E
 +
|identifier=WSI21-148-Case-1_1
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZFdXNVSjlQeUN2TkVldHdFcEdxamV5M0RvNXhHOWFQQ19RaUg3V3NuOVo1aHN3Q0hjaGFvTFROcHVsdkxISUZJdnd3aVUwLUR2N0EteWVRTXhxVklIX0E9PQ
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=September 08, 2021 03:22:10 PM
+
|basedOn=WSI21-148-Case-1
−
|user=Rmn6
+
|type=image
−
|source_filename=Z0FBQUFBQmhPTlZnQVlId1FLbVEtamlXd3R5eFhObFJLbllscnZZTkFpV1Zldlk4eHh1ZHJ2d0J1VXRSNjR1R2dnZUQyWkRJcE40RnVKNkF1WXNrVmFoT1VIenl0eTJFemc9PQ
+
|view=show
−
|slide_stain=H&E
+
|partOf=WSI21-148
−
|slide_anatomy=Show
+
|frames=2
 +
|reasonCode=H&E
 +
|identifier=WSI21-148-Case-1_2
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZnQVlId1FLbVEtamlXd3R5eFhObFJLbllscnZZTkFpV1Zldlk4eHh1ZHJ2d0J1VXRSNjR1R2dnZUQyWkRJcE40RnVKNkF1WXNrVmFoT1VIenl0eTJFemc9PQ
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=September 08, 2021 03:22:10 PM
+
|basedOn=WSI21-148-Case-1
−
|user=Rmn6
+
|type=image
−
|source_filename=Z0FBQUFBQmhPTlZoclF2RkJpSW1PclhzbC1Nc05Meklrc1NtajcyQlpDM3FFSFVSMGhiWUR1ZWJnMGx2a3JzQ25MZEwzM0k5UHZQTHRIVUVjdEgyZDF4S1J0bjJRQmpPaGc9PQ
+
|view=show
−
|slide_stain=Sox10
+
|partOf=WSI21-148
−
|slide_anatomy=Show
+
|frames=3
 +
|reasonCode=Sox10
 +
|identifier=WSI21-148-Case-1_3
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZoclF2RkJpSW1PclhzbC1Nc05Meklrc1NtajcyQlpDM3FFSFVSMGhiWUR1ZWJnMGx2a3JzQ25MZEwzM0k5UHZQTHRIVUVjdEgyZDF4S1J0bjJRQmpPaGc9PQ
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=September 08, 2021 03:22:10 PM
+
|basedOn=WSI21-148-Case-1
−
|user=Rmn6
+
|type=image
−
|source_filename=Z0FBQUFBQmhPTlZvQXNtel9oRl8tUUFFWjh2Z1BVRjBhSnE0akFabFBpSHRZMFY0WUFWcTdwSmx3XzgxbDdNeHQxRDBURzRKZHJjd2FJczljSGktMkV4WlltOE9rejRBd3c9PQ
+
|view=show
−
|slide_stain=fxiii
+
|partOf=WSI21-148
−
|slide_anatomy=Show
+
|frames=4
 +
|reasonCode=fxiii
 +
|identifier=WSI21-148-Case-1_4
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZvQXNtel9oRl8tUUFFWjh2Z1BVRjBhSnE0akFabFBpSHRZMFY0WUFWcTdwSmx3XzgxbDdNeHQxRDBURzRKZHJjd2FJczljSGktMkV4WlltOE9rejRBd3c9PQ
 +
|modality=mrxs
 
}}
 
}}
−
{{wsiSlide
+
{{Media
−
|order_date=September 08, 2021 03:22:10 PM
+
|basedOn=WSI21-148-Case-1
−
|user=Rmn6
+
|type=image
−
|source_filename=Z0FBQUFBQmhPTlY2bkRGUUVNMEFUTkFLbUNOanZEYjNTMnFPTWYyeWhqbkxRUWZIeTRSMGRUSDAwWkV5UTF2VzNqM3RnYXNVUUpTRjFaa0NqUnMyQ012cG5hcjg2RnpjV0E9PQ
+
|view=show
−
|slide_stain=prame
+
|partOf=WSI21-148
−
|slide_anatomy=Show
+
|frames=5
 +
|reasonCode=prame
 +
|identifier=WSI21-148-Case-1_5
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlY2bkRGUUVNMEFUTkFLbUNOanZEYjNTMnFPTWYyeWhqbkxRUWZIeTRSMGRUSDAwWkV5UTF2VzNqM3RnYXNVUUpTRjFaa0NqUnMyQ012cG5hcjg2RnpjV0E9PQ
 +
|modality=mrxs
 +
}}
 +
{{Media
 +
|basedOn=WSI21-148-Case-1
 +
|type=image
 +
|view=show
 +
|partOf=WSI21-148
 +
|frames=2
 +
|reasonCode=H&E
 +
|identifier=WSI21-148-Case-1_2
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZnQVlId1FLbVEtamlXd3R5eFhObFJLbllscnZZTkFpV1Zldlk4eHh1ZHJ2d0J1VXRSNjR1R2dnZUQyWkRJcE40RnVKNkF1WXNrVmFoT1VIenl0eTJFemc9PQ
 +
|modality=mrxs
 +
}}
 +
{{Media
 +
|basedOn=WSI21-148-Case-1
 +
|type=image
 +
|view=show
 +
|partOf=WSI21-148
 +
|frames=3
 +
|reasonCode=Sox10
 +
|identifier=WSI21-148-Case-1_3
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZoclF2RkJpSW1PclhzbC1Nc05Meklrc1NtajcyQlpDM3FFSFVSMGhiWUR1ZWJnMGx2a3JzQ25MZEwzM0k5UHZQTHRIVUVjdEgyZDF4S1J0bjJRQmpPaGc9PQ
 +
|modality=mrxs
 +
}}
 +
{{Media
 +
|basedOn=WSI21-148-Case-1
 +
|type=image
 +
|view=show
 +
|partOf=WSI21-148
 +
|frames=4
 +
|reasonCode=fxiii
 +
|identifier=WSI21-148-Case-1_4
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlZvQXNtel9oRl8tUUFFWjh2Z1BVRjBhSnE0akFabFBpSHRZMFY0WUFWcTdwSmx3XzgxbDdNeHQxRDBURzRKZHJjd2FJczljSGktMkV4WlltOE9rejRBd3c9PQ
 +
|modality=mrxs
 +
}}
 +
{{Media
 +
|basedOn=WSI21-148-Case-1
 +
|type=image
 +
|view=show
 +
|partOf=WSI21-148
 +
|frames=5
 +
|reasonCode=prame
 +
|identifier=WSI21-148-Case-1_5
 +
|createdDateTime=September 08, 2021 03:22:10 PM
 +
|operator=Rmn6
 +
|subject=Z0FBQUFBQmhPTlY2bkRGUUVNMEFUTkFLbUNOanZEYjNTMnFPTWYyeWhqbkxRUWZIeTRSMGRUSDAwWkV5UTF2VzNqM3RnYXNVUUpTRjFaa0NqUnMyQ012cG5hcjg2RnpjV0E9PQ
 +
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Rmn6
 +
|authoredOn=September 08, 2021 03:22:10 PM
 
}}
 
}}

Latest revision as of 15:11, December 9, 2024

WSI21-148-Case-1
61 yo M, left upper arm skin excision. Rule out pleomorphic dermal sarcoma.
Spindled cell/desmoplastic melanoma, level IV (at least), 1.2mm thickness (at least), non-ulcerated, non-mitotic, non-brisk tumor infiltrating lymphocytes, no regression, perineural invasion and microsatellites cannot be assessed. The tumor extends to deep and side margins. PRAME and SOX10 IHC stain positive in epidermal and dermal components, FXIII IHC is negative in lesional cells.
December 31, 1969 7:00:00 PM










Retrieved from "https://learn.mghpathology.org/index.php?title=WSI21-148-Case-1&oldid=141168"
  • Powered by MediaWiki
  • Search Powered by Cargo
  • Massachusetts General Hospital